RFK Jr. Targets Antidepressants, J&J Advances IBD Drug: Key Pharma Updates You Need to Know
U.S. Health Secretary Robert F. Kennedy Jr. announced new initiatives to reduce reliance on widely prescribed antidepressants like Zoloft and Prozac....
U.S. Health Secretary Robert F. Kennedy Jr. announced new initiatives to reduce reliance on widely prescribed antidepressants like Zoloft and Prozac....
Johnson & Johnson’s experimental IBD therapy JNJ-4804, combining Tremfya and Simponi, failed to meet its primary endpoint in Phase 2b trials for ulcer...